In this region, Asia-Pacific POCT device market is projected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024.
Based on geography, the Asia-Pacific POCT market is segmented into 11 geographical regions, such as,
Japan,

China,
South Korea,
India,
Australia,
Singapore,
Thailand,
Malaysia,
Indonesia,
Philippines and
Rest of Asia-Pacific.
Asia-Pacific POCT market competition by top players including -
F. Hoffmann La Roche Diagnostics Limited is dominating the Asia-Pacific POCT device market major players followed by Abbott,
Alere Inc.,
Siemens AG,
Becton, Dickinson and Company,
Johnson & Johnson Services Inc.,
PTS Diagnostics,
Instrumentation Laboratory,
Nova Biomedical,
Beckman Coulter, Inc.,
Werfenlife
The Asia-Pacific POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end user, and geography.
The Asia-Pacific POCT device market is segmented into twelve product types, such asblood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing.
Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections, and respiratory infections testing kit.
Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the Asia-Pacific point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the Asia-Pacific point-of-care testing market is segmented into direct tenders and retail.
On the basis of end users, the Asia-Pacific point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.